AI Assistant
Blog
Pricing
Log In
Sign Up
Oncologic end points and implication of trial design in the era of immunotherapy for resectable non–small cell lung cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
